Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMMDNA8)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2-(3-mercaptopropyl)pentanedioic acid; 2-MPPA; 2-(3-sulfanylpropyl)pentanedioic Acid; 254737-29-6; CHEMBL303352; Pentanedioic acid, 2-(3-mercaptopropyl)-; 2-[3-mercaptopropyl]pentanedioic acid; GPI 5693; SCHEMBL787800; CTK0J4030; BDBM17755; FNLNSQHJKVQCBP-UHFFFAOYSA-N; MolPort-035-765-922; pentanedioic acid analogue, (RS)-3; AKOS024458465
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||